FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2533742416> ?p ?o ?g. }

• W2533742416 abstract "9521 Background: Fractalkine (FKN) is a unique CX3C chemokine (CX3CL1) known to induce adhesion and migration of leukocytes mediated by a membrane-bound and a soluble form. Methods: We found that FKN is expressed in >90% of 68 neuroblastoma (NB) samples as determined by cDNA microarray analysis. FKN expression was inversely correlated with MYCN amplification, suggesting a higher expression of FKN in MYCN non amplified tumors. We characterized the effect of FKN in the neuroblastoma microenvironment in a mouse model. We demonstrate that FKN released from NB cells mediate migration and adhesion of CD4 + -, CD8 + - and NK- cells and subsequent secretion of IFN-γ, in vitro and in vivo. However, the presence of FKN in NB microenvironments did not result in significant anti-NB activity. Results: Targeting of IL-2 into the NB microenvironment using anti-ganglioside GD2 antibody cytokine fusion proteins (ch14.18-IL-2) is currently under clinical evaluation. We investigated a the role of FKN in this context. For this purpose, IL-2 was targeted to GD2 positive NB microenvironments secreting FKN. Only mice bearing FKN and IL2 enriched NB microenvironments exhibited a reduction in primary tumor growth and a complete eradication of experimental liver metastases, in contrast to controls with only FKN or IL-2 enriched NB. This effect was specific since a non-specific antibody-IL-2 fusion protein ch225-IL-2 was ineffective. The mechanisms involved included NK-cell activation by targeted IL-2 into FKN rich NB as indicated by the enhancement of NK-cell mediated lysis using YAC-1 cells as targeted cells. The depletion of NK cells in vivo inhibited the therapeutic effect. Furthermore, co-culture of NXS2-FKN cells and NK cells in vitro induced the expression of IFN-γ by NK cells. However, the depletion of CD8 + T-cells in vivo abrogated the therapeutic effect, and these effector cells showed the highest cytolytic activity against NXS2 target cells in vitro. Finally, only the FKN and IL-2 enriched NB microenvironment resulted in T-cell activation and the release of proinflammatory cytokines. Conclusions: In conclusion our data suggest that targeted IL-2 therapy of FKN rich NB associated with MYCN non-amplified tumors may result in T-cell mediated immune responses. No significant financial relationships to disclose." @default.
• W2533742416 created "2016-10-28" @default.
• W2533742416 creator A5017520053 @default.
• W2533742416 creator A5018970052 @default.
• W2533742416 creator A5040842902 @default.
• W2533742416 creator A5084819547 @default.
• W2533742416 date "2007-06-20" @default.
• W2533742416 modified "2023-10-03" @default.
• W2533742416 title "Role of fractalkine (CX3CL1) rich neuroblastoma microenvironments for ganglioside GD2 directed immunotherapy" @default.
• W2533742416 doi "https://doi.org/10.1200/jco.2007.25.18_suppl.9521" @default.
• W2533742416 hasPublicationYear "2007" @default.
• W2533742416 type Work @default.
• W2533742416 sameAs 2533742416 @default.
• W2533742416 citedByCount "0" @default.
• W2533742416 crossrefType "journal-article" @default.
• W2533742416 hasAuthorship W2533742416A5017520053 @default.
• W2533742416 hasAuthorship W2533742416A5018970052 @default.
• W2533742416 hasAuthorship W2533742416A5040842902 @default.
• W2533742416 hasAuthorship W2533742416A5084819547 @default.
• W2533742416 hasConcept C12823836 @default.
• W2533742416 hasConcept C13373296 @default.
• W2533742416 hasConcept C178790620 @default.
• W2533742416 hasConcept C185592680 @default.
• W2533742416 hasConcept C203014093 @default.
• W2533742416 hasConcept C2776914184 @default.
• W2533742416 hasConcept C2777331542 @default.
• W2533742416 hasConcept C2777701055 @default.
• W2533742416 hasConcept C502942594 @default.
• W2533742416 hasConcept C55493867 @default.
• W2533742416 hasConcept C71924100 @default.
• W2533742416 hasConcept C82321936 @default.
• W2533742416 hasConcept C84416704 @default.
• W2533742416 hasConcept C86803240 @default.
• W2533742416 hasConcept C8891405 @default.
• W2533742416 hasConcept C95444343 @default.
• W2533742416 hasConceptScore W2533742416C12823836 @default.
• W2533742416 hasConceptScore W2533742416C13373296 @default.
• W2533742416 hasConceptScore W2533742416C178790620 @default.
• W2533742416 hasConceptScore W2533742416C185592680 @default.
• W2533742416 hasConceptScore W2533742416C203014093 @default.
• W2533742416 hasConceptScore W2533742416C2776914184 @default.
• W2533742416 hasConceptScore W2533742416C2777331542 @default.
• W2533742416 hasConceptScore W2533742416C2777701055 @default.
• W2533742416 hasConceptScore W2533742416C502942594 @default.
• W2533742416 hasConceptScore W2533742416C55493867 @default.
• W2533742416 hasConceptScore W2533742416C71924100 @default.
• W2533742416 hasConceptScore W2533742416C82321936 @default.
• W2533742416 hasConceptScore W2533742416C84416704 @default.
• W2533742416 hasConceptScore W2533742416C86803240 @default.
• W2533742416 hasConceptScore W2533742416C8891405 @default.
• W2533742416 hasConceptScore W2533742416C95444343 @default.
• W2533742416 hasLocation W25337424161 @default.
• W2533742416 hasOpenAccess W2533742416 @default.
• W2533742416 hasPrimaryLocation W25337424161 @default.
• W2533742416 hasRelatedWork W112705378 @default.
• W2533742416 hasRelatedWork W1994888681 @default.
• W2533742416 hasRelatedWork W2007642862 @default.
• W2533742416 hasRelatedWork W2013060765 @default.
• W2533742416 hasRelatedWork W2070463916 @default.
• W2533742416 hasRelatedWork W2109876118 @default.
• W2533742416 hasRelatedWork W2126005292 @default.
• W2533742416 hasRelatedWork W2146036781 @default.
• W2533742416 hasRelatedWork W2792112922 @default.
• W2533742416 hasRelatedWork W4283772193 @default.
• W2533742416 isParatext "false" @default.
• W2533742416 isRetracted "false" @default.
• W2533742416 magId "2533742416" @default.
• W2533742416 workType "article" @default.